COVID-19防控捐赠药品管理策略

Xiaolin Xu, Li Yang, Chen Chen, S. Zhai, Rongsheng Zhao
{"title":"COVID-19防控捐赠药品管理策略","authors":"Xiaolin Xu, Li Yang, Chen Chen, S. Zhai, Rongsheng Zhao","doi":"10.11669/CPJ.2020.09.006","DOIUrl":null,"url":null,"abstract":"OBJECTIVE: To provide reference of donated drugs management for pharmaceutical departments during public health emergencies, so as to ensure the quality, safety and reasonable use of donated drugs. METHODS: Combined with the legal requirements and common problems of donated drugs, explore scientific and reasonable donated drug management principles, and establish donated drug management systems and processes. RESULTS: In the past, when medical institutions responded to major public health emergencies, there were some problems in the management of the demand, qualification and quality, validity, use, price, and surplus drugs of donated drugs. According to the requirements of the relevant laws, regulations and guidance on the characteristics, management, use and communication between donors and recipients of donated drugs, we established a scientific, reasonable and orderly management model, and clarified the management system, method and comprehensive management process. CONCLUSION: The problems, principles and models of donated drugs management were sorted out comprehensively, which is helpful to prevent and control of coronavirus disease 2019 (COVID-19).","PeriodicalId":22409,"journal":{"name":"The Chinese Pharmaceutical Journal","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2020-05-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":"{\"title\":\"Management Strategy on Donated Medicines for COVID-19 Prevention and Control\",\"authors\":\"Xiaolin Xu, Li Yang, Chen Chen, S. Zhai, Rongsheng Zhao\",\"doi\":\"10.11669/CPJ.2020.09.006\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"OBJECTIVE: To provide reference of donated drugs management for pharmaceutical departments during public health emergencies, so as to ensure the quality, safety and reasonable use of donated drugs. METHODS: Combined with the legal requirements and common problems of donated drugs, explore scientific and reasonable donated drug management principles, and establish donated drug management systems and processes. RESULTS: In the past, when medical institutions responded to major public health emergencies, there were some problems in the management of the demand, qualification and quality, validity, use, price, and surplus drugs of donated drugs. According to the requirements of the relevant laws, regulations and guidance on the characteristics, management, use and communication between donors and recipients of donated drugs, we established a scientific, reasonable and orderly management model, and clarified the management system, method and comprehensive management process. CONCLUSION: The problems, principles and models of donated drugs management were sorted out comprehensively, which is helpful to prevent and control of coronavirus disease 2019 (COVID-19).\",\"PeriodicalId\":22409,\"journal\":{\"name\":\"The Chinese Pharmaceutical Journal\",\"volume\":\"1 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-05-08\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Chinese Pharmaceutical Journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.11669/CPJ.2020.09.006\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Chinese Pharmaceutical Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.11669/CPJ.2020.09.006","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

摘要

目的:为突发公共卫生事件中药学部门捐赠药品管理提供参考,确保捐赠药品的质量、安全和合理使用。方法:结合法律要求和捐赠药品存在的常见问题,探索科学合理的捐赠药品管理原则,建立捐赠药品管理制度和流程。结果:以往医疗机构应对重大突发公共卫生事件时,对捐赠药品的需求、资质质量、有效性、使用、价格、剩余药品等管理存在一定问题。根据相关法律法规和指导意见对捐赠药品的特点、管理、使用、捐赠人与受赠人之间的沟通等方面的要求,建立了科学、合理、有序的管理模式,明确了管理制度、方法和综合管理流程。结论:全面梳理了捐赠药品管理存在的问题、原则和模式,有助于防控2019冠状病毒病。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Management Strategy on Donated Medicines for COVID-19 Prevention and Control
OBJECTIVE: To provide reference of donated drugs management for pharmaceutical departments during public health emergencies, so as to ensure the quality, safety and reasonable use of donated drugs. METHODS: Combined with the legal requirements and common problems of donated drugs, explore scientific and reasonable donated drug management principles, and establish donated drug management systems and processes. RESULTS: In the past, when medical institutions responded to major public health emergencies, there were some problems in the management of the demand, qualification and quality, validity, use, price, and surplus drugs of donated drugs. According to the requirements of the relevant laws, regulations and guidance on the characteristics, management, use and communication between donors and recipients of donated drugs, we established a scientific, reasonable and orderly management model, and clarified the management system, method and comprehensive management process. CONCLUSION: The problems, principles and models of donated drugs management were sorted out comprehensively, which is helpful to prevent and control of coronavirus disease 2019 (COVID-19).
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Research Progress of Pharmacokinetic Interactions between Lopinavir/Ritonavir and Statins Results and Discussion on National Vaccine Proficiency Testing Schemes in 2020 Case Study of Icotinib on The Impact of Domestic Innovative Drugs Timely Covered by Medical Insurance Evaluation of α-Interferon Applied in COVID-19 Therapy Regimen Detection and Analysis of Safety Signals of Chloroquine Based Upon FDA Adverse Event Database
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1